LAUNCH ONE ACQUISITION CORP (LPAA) Stock News

NASDAQ:LPAA - Nasdaq - KYG5S86M1005 - Common Stock - Currency: USD

10.43 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

LPAA Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: LaunchOne Acquisition Corp

News Image

Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by Growth

a month ago - By: LaunchOne Acquisition Corp

News Image

Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome

a month ago - By: LaunchOne Acquisition Corp

News Image

Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Markets